FTC (Emtricitabine, Emtriva): News & Research
- Clinical Trials Using Emtricitabine (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health
- Switching to Rilpivirine/Tenofovir/FTC Fixed-Dose Combination From Boosted-PI Regimen: SPIRIT Study Draws the Line at 24 Weeks (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Gilead and Tibotec Agree on New Single-Tablet Regimen (November 23, 2011)
In Positively Aware, from Test Positive Aware Network
- Gilead and J&J Expand HIV Cocktail Partnership (November 16, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead Raises Prices of HIV Drugs, AHF Speaks Out Against Price Hike (April 4, 2011)
In Bloomberg Businessweek
- Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- Emtriva: New Pediatric Formulation and Labeling Changes (September 28, 2005)
From U.S. Food and Drug Administration
- Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
- Food and Drug Administration to Expedite Decision on Emtricitabine/Tenofovir Pill (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Emtricitabine: A New Nucleoside Analogue for Once-Daily Antiretroviral Therapy (January 2004)
In Expert Opinion on Investigational Drugs
- Effective Once-Daily HIV Regimen (October 2003)
From the 2nd International AIDS Society Conference.
In HIV Treatment ALERTS!, from The Center for AIDS
- FDA Bits (October 1, 2003)
In HIV Treatment ALERTS!, from The Center for AIDS
- No PK Interaction Seen Between FTC and AZT or Tenofovir (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- FTC Compares Well to 3TC in Triple-NRTI Regimens (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- FTC Similar in Most Ways to 3TC (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- Emtricitabine (September 2003)
2nd International AIDS Society Conference on HIV Pathogenesis and Treatment.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- A New Once a Day Nucleoside: Emtriva -- A New Option in Once Daily HIV Therapy (August 12, 2003)
In STEP Ezine, from Seattle Treatment Education Project
- FTC (Emtriva) Approved (July 25, 2003)
In AIDS Treatment News, from AIDS Treatment News
|
Advertisement
|
Email
Glossary
